基于Pik3ap1-PI3K/AKT通路探讨围刺促乳腺癌血管正常化作用机制
批准号:
82074545
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
黄金昶
依托单位:
学科分类:
中医针灸学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
黄金昶
中文摘要
血管正常化明显提高放化疗及免疫监测点抑制剂疗效。临床与动物实验证实围刺明显提高化疗疗效,但机制不明确。团队前期发现围刺明显促乳腺癌血管正常化,并初步得出正常化时间窗,蛋白组学示围刺通过PI3K/AKT通路促血管正常化,Pik3ap1表达抑制最明显,据此提出假说“围刺通过Pik3ap1-PI3K/AKT通路促血管正常化”。. 本研究拟采用活体光声成像配合组织血管结构功能检测确定围刺促血管正常化时间窗;观察周细胞、内皮细胞超微结构与分子变化,明确血管正常化形态与分子特征。对比观察Pik3ap1-PI3K/AKT通路蛋白变化明确围刺作用靶基因;用CRISPR/Cas9技术建立Pik3ap1敲除4T1乳腺癌模型,观察围刺后Pik3ap1-PI3K/AKT通路蛋白变化验证Pik3ap1是围刺作用核心靶点,阐释围刺促血管正常化分子机制,为肿瘤血管正常化研究提供针刺方案。
英文摘要
Tumor vascular normalization improves the efficacy of radiotherapy, chemotherapy and immune checkpoint inhibitor. Clinical and animal experiments have proved that peritumoral needling can significantly improve the chemotherapy effect, but the mechanism is not clear.Our early study showed that peritumoral needling significantly promoted the local enrichment of chemotherapy drugs in breast cancer, the vascular normalization time window was preliminarily verified by photoacoustic imaging in vivo and detection of SMA, VEGFA and HIF1 expression in tissue. Proteomics indicated that peritumoral needling promoted tumor vascular normalization via PI3K/AKT signaling pathway. Pik3ap1 was a unique member of PI3K family which was significantly inhibited. Hence a hypothesis was put forward that peritumoral needling promoted tumor vascular normalization via Pik3ap1-PI3K/AKT signaling pathway..In this study, we intend to confirm the vascular normalization time window by photoacoustic imaging in vivo and structure and function detection of tumor vasculature in vitro. Changes of ultrastructure and related molecules of pericyte and endothelial cells will be observed to clarify the morphological and molecular characteristics of vascular normalization. The target genes of peritumoral needling will be identified by comparing and observing the protein changes of pik3ap1-pi3k / Akt signaling pathway. The pk3ap1-null 4T1 breast cancer mice model will be established through CRISPR / cas9 technology, and the core role of pik3ap1 will be verified by observing the protein changes of pik3ap1-pi3k / Akt signaling pathway after peritumoral needling treatment. We aim to uncover the molecular mechanism of vascular normalization induced by peritumoral needling, which provides an acupuncture regimen for tumor vascular normalization.
研究背景:乳腺癌血管正常化是有效促进放化疗及免疫监测点抑制剂疗效的干预策略,周细胞-内皮细胞crosstalk是血管正常化的关键环节,围刺既可靶向调控肿瘤微环境,又可沟通肿瘤局部经脉、络脉、浮络和皮部之间的联系,前期研究发现围刺能显著提高化疗疗效,并促进4T1乳腺癌移植瘤血管正常化,但具体时间窗范围不明确。同时该效应通过蛋白组学筛选发现与Pik3ap1-PI3K/AKT相关,但机制尚不清楚有待验证。.研究内容:①构建Balb/c nude 4T1乳腺癌移植瘤模型,随机分为模型组(TG)、围刺组(EATG)、贝伐组(BTG),运用活体光声成像技术联合离体组织血管结构和功能正常化参数指标共同明确围刺促血管正常化作用效应及时间窗范围。②观察围刺促肿瘤血管正常化过程中周细胞-内皮细胞 crosstalk 动态变化,电镜观察血管周细胞、内皮细胞,并通过免疫组化/免疫荧光、qPCR、Western blot方法检测周细胞、内皮细胞相关分子蛋白表达水平。③检测PDGFB/PDGFR轴、VEGF/VEGFR轴和Pik3ap1-PI3K/AKT通路中的主要分子表达水平,并进一步通过CRISPR/Cas9技术制备4T1乳腺癌Pik3ap1敲除模型,在血管正常化效应最佳时间点对血管结构指标、血管功能指标及Pik3ap1-PI3K/AKT通路重要分子检测。.研究结果:①瘤周围刺促进4T1乳腺癌移植瘤血管正常化,具体表现为减少微血管密度、促进周细胞覆盖和基底膜完整,并改善灌注、乏氧,减少渗漏,时间窗范围为干预后2-5天,干预后第3天为效应最佳时间点。②瘤周围刺促进4T1乳腺癌移植瘤血管正常化的过程中,围刺能够调控周细胞-内皮细胞crosstalk的形态和分子交互轴,抑制了VEGFA、VEGFR2、PHD、FLT1、EGF、RGS5、CXCR4、NRP1的表达。③瘤周围刺促4T1乳腺癌移植瘤血管正常化与调控Pik3ap1-PI3K/AKT信号途径密切相关。围刺能够有效抑制PI3K/AKT通路中MEK、CDK6、THBS2、AKT、eNOS的表达,并促进GNG5的表达。④Pik3ap1是瘤周围刺促4T1乳腺癌移植瘤血管正常化的关键作用靶点。敲除Pik3ap1后,围刺促4T1乳腺癌移植瘤血管正常化作用受到显著的限制,Pik3ap1是围刺促4T1乳腺癌移植瘤血管正常化的重要作用靶点。
基于乳腺癌相关成纤维细胞糖酵解代谢途径GLO1-MGO探讨围刺降低肿瘤硬度的机制研究
-
批准号:82575232
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2025
-
负责人:黄金昶
-
依托单位:
扶正增效方对S100A9与CyPA在非小细胞肺癌放射增敏作用的调控机制
-
批准号:81573736
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:黄金昶
-
依托单位:
国内基金
海外基金